Allspring Global Investments Holdings LLC Decreases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Allspring Global Investments Holdings LLC cut its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 47.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 9,709 shares of the medical instruments supplier’s stock after selling 8,611 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in LeMaitre Vascular were worth $551,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Exchange Traded Concepts LLC increased its holdings in shares of LeMaitre Vascular by 0.8% in the fourth quarter. Exchange Traded Concepts LLC now owns 23,656 shares of the medical instruments supplier’s stock valued at $1,343,000 after purchasing an additional 187 shares during the period. Riverwater Partners LLC raised its stake in shares of LeMaitre Vascular by 2.5% in the fourth quarter. Riverwater Partners LLC now owns 8,216 shares of the medical instruments supplier’s stock worth $466,000 after purchasing an additional 198 shares during the last quarter. Swiss National Bank raised its stake in shares of LeMaitre Vascular by 1.2% in the third quarter. Swiss National Bank now owns 43,900 shares of the medical instruments supplier’s stock worth $2,392,000 after purchasing an additional 500 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of LeMaitre Vascular by 0.7% in the third quarter. Victory Capital Management Inc. now owns 76,915 shares of the medical instruments supplier’s stock worth $4,190,000 after purchasing an additional 557 shares during the last quarter. Finally, Linden Thomas Advisory Services LLC raised its stake in shares of LeMaitre Vascular by 2.0% in the third quarter. Linden Thomas Advisory Services LLC now owns 29,157 shares of the medical instruments supplier’s stock worth $1,588,000 after purchasing an additional 568 shares during the last quarter. 84.64% of the stock is currently owned by hedge funds and other institutional investors.

LeMaitre Vascular Trading Down 1.6 %

Shares of LMAT stock opened at $62.99 on Friday. The stock has a 50 day moving average of $65.30 and a 200 day moving average of $58.05. The stock has a market cap of $1.41 billion, a P/E ratio of 47.01, a P/E/G ratio of 2.77 and a beta of 0.87. LeMaitre Vascular, Inc. has a twelve month low of $44.27 and a twelve month high of $74.64.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. The business had revenue of $48.90 million during the quarter, compared to analysts’ expectations of $49.01 million. LeMaitre Vascular had a return on equity of 10.57% and a net margin of 15.56%. The business’s revenue was up 19.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.25 earnings per share. On average, research analysts predict that LeMaitre Vascular, Inc. will post 1.66 earnings per share for the current fiscal year.

LeMaitre Vascular Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Thursday, March 14th were given a $0.16 dividend. The ex-dividend date of this dividend was Wednesday, March 13th. This is a boost from LeMaitre Vascular’s previous quarterly dividend of $0.14. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.02%. LeMaitre Vascular’s payout ratio is 47.76%.

Wall Street Analyst Weigh In

LMAT has been the subject of several research analyst reports. KeyCorp initiated coverage on LeMaitre Vascular in a research note on Tuesday, February 6th. They issued a “sector weight” rating for the company. StockNews.com cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Tuesday, April 16th. Finally, Barrington Research raised their price objective on LeMaitre Vascular from $66.00 to $69.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 28th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, LeMaitre Vascular presently has a consensus rating of “Moderate Buy” and an average target price of $68.20.

Insider Activity

In other news, CFO Joseph P. Pellegrino, Jr. sold 36,967 shares of the business’s stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $69.76, for a total value of $2,578,817.92. Following the completion of the sale, the chief financial officer now directly owns 6,452 shares in the company, valued at $450,091.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Joseph P. Pellegrino, Jr. sold 36,967 shares of LeMaitre Vascular stock in a transaction that occurred on Thursday, February 29th. The stock was sold at an average price of $69.76, for a total value of $2,578,817.92. Following the sale, the chief financial officer now directly owns 6,452 shares of the company’s stock, valued at $450,091.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Lawrence J. Jasinski sold 5,110 shares of LeMaitre Vascular stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $67.50, for a total value of $344,925.00. Following the completion of the sale, the director now directly owns 5,309 shares in the company, valued at $358,357.50. The disclosure for this sale can be found here. Insiders sold 114,036 shares of company stock worth $7,873,749 over the last three months. 10.79% of the stock is currently owned by corporate insiders.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.